Table 3. Response to i-HDS in 92... | American Society of Hematology

Table 3.

Response to i-HDS in 92 evaluable patients (100%)

Toxic deaths

2 (2%)

Progressions

3 (3%)

Partial responses

6 (6%)

Complete responses

81 (88%)

Toxic deaths	2 (2%)
Progressions	3 (3%)
Partial responses	6 (6%)
Complete responses	81 (88%)

This Feature Is Available To Subscribers Only

Sign In or Create an Account